Jae Hee Cheon

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 277 citations

Immunology, Clinical Trials, Gastroenterology +7

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Byong Duk Ye, Marina Pesegova, Olga Alexeeva et al. · The Lancet · 2019 · 203 citations · Full text

Biosimilar Ct-p13, Originator Infliximab, Gastroenterology +5

The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

Jin Ha Lee, Tae Il Kim, Soung Min Jeon et al. · International Journal of Cancer · 2011 · 201 citations

Metabolic Syndrome, Diabetes Management, Cancer Epidemiology +15

Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-β Production

Jin‐Young Yang, Min‐Soo Kim, Eugene Kim et al. · Immunity · 2016 · 198 citations · Full text

Inflammation, Toll-like Receptors, Host Response +11

Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations

Suk‐Kyun Yang, Myunghee Hong, Wanting Zhao et al. · Gut · 2013 · 183 citations · Full text